Oral Antidiabetic Drugs Market by Drugs Class Category (Sulfonylureas, Meglitinides, Biguanides and Alpha-glucosidase inhibitors) for Type 2 Diabetes mellitus - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Global oral antidiabetic drug market is expected to reach USD 35.91 billion by 2022, growing at a CAGR of 10.2% between 2017 and 2022.

06-Jan-2017 | Number of pages: 110 | Report Code: ZMR-687 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the oral antidiabetic drugs market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD billion). The study includes drivers and restraints of the oral antidiabetic drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the oral antidiabetic drugs market on a global level.

In order to give the users a comprehensive view of the Oral antidiabetic drugs market, we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the oral antidiabetic drugs market has also been included. The study encompasses a market attractiveness analysis, wherein the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the oral antidiabetic drugs market by segmenting the market based on drugs class and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. The drugs class segmentation includes sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. The meglitinides class is further segmented into repaglinide and nateglinide. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further sub-segmented into U.S., Canada, China, Japan, and Brazil.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global oral antidiabetic drugs market include Eli Lilly, Abbott, Biocon, Sanofi, Sunpharma, Novartis, Novo Nordisk, Merck and Pfizer.

This report segments the global oral antidiabetic drugs Market as follows:

Global Oral Antidiabetic Drugs Market: Drugs Class Analysis

  • Sulfonylureas
    • Glimepiride
    •  Gliclazide
    •  Glyburide
    •  Others
  • Meglitinides
  • Repaglinide
  • Nateglinide
  • Biguanides
    • Metformin
    •  Others
  • Alpha-glucosidase inhibitors
    • Acarbose
    •  Voglibose
    •  Others
  • Others

Global Oral Antidiabetic Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Dehydration Monitoring Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2270 | Report Format:

Dehydration Monitoring Systems Market: Growth Factors The major factors that are driving the growth of the dehydration monitoring systems are the shifting focus of the individuals towards fitness and smart health choices, availability of the cost effective and improved versions of the dehydratio...Read More

Vegetarian Capsules Market by Product type (Pullulan, Starch, HPMC) and End-users (Pharmaceutical Companies, Nutraceutical Companies, CMO’s and Cosmetic Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Sep-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2244 | Report Format:

The report covers forecast and analysis for the vegetarian capsules market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the vegetarian capsules market alon...Read More

Anti-Infective Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2239 | Report Format:

Anti-Infective Vaccines Market: Overview With the help of the drugs, anti-infective, and antiviral agents, the infectious diseases are treated. These agents are coupled with the boosters. In order to avoid the rapid spread of the infectious diseases, the healthcare organizations take the prevent...Read More

Seasonal Influenza Vaccines Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2233 | Report Format:

Seasonal Influenza Vaccines Therapeutics Market: Overview Influenza vaccine is also called as the flu shot. It is used to protect against the infection of the influenza virus. An influenza vaccine has a mixture of 3 viruses type which includes influenza type B virus strain, influenza type A havi...Read More

Probiotic Ingredients Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2227 | Report Format:

Probiotic Ingredients Market: Overview Probiotics are usually microorganisms, for instance, bacteria and yeast, that actually benefit humans as well as animals by taking care of their intestines and providing good bacteria in the body, which helps in digestion process. Probiotic ingredients arou...Read More

Choose License Type:
Latest Published Reports

View All Published Reports